Why Veterans With Treatment-Resistant Depression Are Finding Hope in Ketamine Therapy

Ketamine infusion therapy is delivering measurable relief for veterans struggling with treatment-resistant depression (TRD)—a condition where standard antidepressants fail to work. New data from VA medical centers shows that 70% of veterans treated with IV ketamine experienced a reduction of at least 50% in their depression symptoms, while 56% of those with suicidal thoughts saw those thoughts decrease after treatment. For a population that has historically faced limited options, ketamine represents a genuine breakthrough.

What Makes Ketamine Different From Traditional Antidepressants?

Unlike oral antidepressants that can take weeks or months to work, ketamine acts on the brain through a completely different mechanism. Traditional antidepressants target serotonin levels, but ketamine works on the glutamate system—essentially resetting neural pathways that have become stuck in depression patterns. This is why it's called "treatment-resistant depression" in the first place: the brain has stopped responding to conventional medications.

The speed matters enormously for veterans in crisis. When someone is experiencing severe suicidal ideation, waiting six weeks for an antidepressant to kick in isn't an option. Ketamine can provide relief in days or weeks, not months. Among veterans with baseline suicidal ideation, 56% showed a measurable decrease in those thoughts after their ketamine induction phase.

How Does Ketamine Treatment Actually Work?

Ketamine therapy at VA medical centers involves a structured clinical protocol. Veterans receive IV infusions in a monitored medical setting, where nurses track vital signs including heart rate, blood pressure, oxygen levels, and respiration throughout the procedure. The treatment requires a psychiatrist, registered nurses, pharmacy staff, and medical support to ensure safety and proper dosing.

The typical treatment timeline unfolds over several phases. During the initial induction period—usually spanning weeks—veterans receive multiple infusions to establish the therapeutic effect. Then, maintenance infusions help sustain the improvement. With repeated ketamine infusion therapy, 86% of veterans clinically showed significant improvement in treatment-resistant depression due to the enhanced therapeutic benefit.

Steps to Access Ketamine Therapy Through the VA

• Contact Your Primary Mental Health Provider: Veterans should reach out to their local VA Medical Center's (VAMC) primary mental health provider to discuss whether ketamine therapy might be appropriate for their specific situation.
• Request an Evaluation: The mental health team will assess whether you meet criteria for treatment-resistant depression and evaluate your overall health to ensure ketamine is safe for you.
• Connect With Community Care Office: If your local VA doesn't yet offer ketamine therapy, the Community Care Office can help explore options or discuss when the service might become available at your facility.
• Access Crisis Support Anytime: Veterans in mental health crisis don't need to wait for an appointment—call the Veterans Crisis Line by dialing 988 and pressing 1, available 24/7 with trained responders, many of whom are veterans themselves.

Why Cost Matters for Widespread Access

One of the most compelling arguments for expanding ketamine therapy across the VA system is the dramatic cost difference between treatment options. IV ketamine costs approximately $1,700 annually to treat eight veterans, while esketamine (a nasal spray version) costs between $1,157,000 and $3,729,600 annually to treat 100 veterans. This massive disparity means that IV ketamine could be scaled across the entire VA system without breaking budgets—potentially saving lives while actually reducing healthcare costs.

The innovation has already begun spreading. Starting in December 2019 at John L. McClellan Memorial Veterans' Hospital in Little Rock, Arkansas, the ketamine clinic model has been recognized as a "Diffusion of Excellence" promising practice and won the VHA Shark Tank competition for innovation. Additional VA facilities began adoption in October 2024, with the program continuing to expand.

What About Veterans Who Aren't Responding to Anything Else?

Treatment-resistant depression affects roughly one-third of veterans diagnosed with depression—meaning they've already tried multiple antidepressants without adequate relief. For this population, the stakes are extraordinarily high. Untreated depression in veterans leads to poor quality of life, social isolation, decreased work productivity, and tragically, increased suicide risk. Ketamine therapy offers a second chance when conventional medicine has failed.

The VA's mission with ketamine therapy is explicit: to give "all American heroes a second chance at life." Veterans experiencing a mental health emergency are urged to call the Veterans Crisis Line (dial 988, then press 1), present to the nearest emergency room, or call 911 immediately. Help is free to all veterans 24/7, even if they are not enrolled in VA benefits or health care.

If you're a veteran struggling with depression that hasn't improved with standard treatments, or if you're concerned about a fellow veteran, ketamine therapy is no longer an experimental option—it's an evidence-based treatment available through the VA system. The data shows it works. The question now is whether you'll take the step to explore it.